Purchase Order 75N94020P00856

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC on September 14, 2020, for an ID3 multi-mode microplate detection platform at a ceiling value of $25,000.00. Place of performance is San Jose, California. The order was issued under firm fixed-price terms with an ultimate completion date of September 30, 2020. The procurement was not set-aside and originated from a pre-solicitation opportunity posted on September 13, 2020.

<p>The National Heart Lung and Blood Institute issued a purchase order to Molecular Devices LLC for a SpectraMax ID3 multi-mode microplate reader valued at $30,343.10, awarded August 31, 2020, with a performance deadline of September 30, 2020. Work is performed at the vendor's facility in San Jose, California. The order is firm fixed price with no small business set-aside. The underlying opportunity was posted August 18, 2020 with a due date of August 25, 2020.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC valued at $2,163.00 on March 31, 2016. The order is a firm fixed price modification to de-obligate expired lines. Place of performance is Sunnyvale, California. The ultimate completion date is April 30, 2016.</p>

This purchase order awarded by the Department of Health and Human Services' National Institutes of Health to Molecular Devices LLC will provide a SpectraMax iD5 Standard Multi-Mode Microplate Detection Platform and associated on-site compliance assurance digital IQ/OQ service visit. Valued at $42,114.79, this firm fixed price contract supports the National Institute of Digestive, Diabetes and Kidney Diseases' research efforts through delivery of the requested detection platform and ensuring it...

The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $5,227.52 purchase order contract to Molecular Devices LLC for depot service of a SpectraMax M5 spectrophotometer. The firm fixed price contract runs from October 20, 2010 to October 24, 2011 and requires Molecular Devices LLC to provide quarterly billing for maintenance of the equipment. Molecular Devices LLC will perform as the prime...

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Molecular Devices LLC for $11,339.21 on August 19, 2018. The firm fixed price order, which expired on August 23, 2019, was placed without a set-aside designation. Performance occurred in San Jose, California. The order procured bioanalytical measurement solutions and related scientific equipment from the vendor, a for-profit LLC specializing in advanced laboratory instruments for life science...

This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $25,969 contract provides a base year plus three option years of maintenance, repair, and preventive services for a SpectraMax iD3 plate reader used by NIDDK labs. The contract was awarded on a sole-source, non-competitive basis as Molecular Devices...

Molecular Devices LLC, a San Jose, California-based subsidiary of Danaher Corporation, was awarded a $28,624 firm fixed-price purchase order by the Pacific West Area civilian federal agency on September 27, 2019, for a SpectraMax ID3 multi-mode microplate detection platform system. The contract, which carried no set-aside designation, was to be completed by November 30, 2019, with performance taking place at the contractor's San Jose facility. The solicitation was posted on September 23, 2019,...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,168.70 firm fixed-price purchase order to Molecular Devices LLC for a SPECTRAMAX MICROPLATE READER (AMBIS #2183390). Performance will take place in San Jose, California over a period of approximately four months concluding in late December 2023. As part of its mission to conduct and support medical research, the funding agency likely requires the...

This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract has a ceiling value of $96,433.00 and a completion date of September 30, 2016. Molecular Devices is a leading provider of bioanalytical measurement solutions, including specialized laboratory instruments, equipment,...